Navigation Links
Amikacin Inhale Shows Promising Results in Phase II Study
Date:5/19/2008

d treating diseases. Find more information at http://www.bayerhealthcare.com.

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development platforms. Nektar PEGylation and pulmonary technology, expertise, manufacturing capabilities have enabled nine approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its pulmonary and PEGylation technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance. Find more information at http://www.nektar.com.

Contacts

Bayer HealthCare Nektar Therapeutics

Yvonne Moller Stephan Herrera

Tel.: +49 (0) 30 468 17 389 Tel.: +1 (415) 488-7699

E-mail: yvonne.moeller@bayerhealthcare.com E-mail: sherrera@nektar.com

Forward-Looking Statements

Bayer - This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to confo
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
2. Inhaled Steriods Used as Preventive Treatment Post 9/11
3. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
4. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
5. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
6. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
7. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
8. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
11. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswire... that the Anti-infective Drugs Advisory Committee ...s voted 17 to 2 against the,approval of intraveno...t for,the treatment of patients with complicated ...uding those caused by methicillin-resistant Staphy...
(Date:11/20/2008)... LA JOLLA, Calif., Nov. 20 /PRNewswire-FirstCall/ ... DSKA), announced today that it has submitted its,...r review under a Special,Protocol Assessment (SPA...tion,(FDA). , Subject to securing an agree...ngle, prospective, double-blind, placebo-controlle...
(Date:11/20/2008)... BOSTON, Nov. 20 PAREXEL...ading global biopharmaceutical services provider, ...ma, Peru to provide regulatory consulting and clin...he Peru office, PAREXEL now has locations througho...in America, which also include Argentina, Brazil, ...
(Date:11/19/2008)... THOUSAND OAKS, Calif., Nov. 19 /PRNewswire-FirstC...he Takeda Oncology Company, a subsidiary of,Taked...y announced that,enrollment in the Phase 3 MONET1...ion with paclitaxel and carboplatin for the first-...ncer (NSCLC) has been temporarily suspended,follo...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7High Blood Pressure May Heighten Effects of Alzheimers Disease 934 1High Blood Pressure May Heighten Effects of Alzheimers Disease 934 2Transporters may help delay diabetes related retinal damage 7116 1Transporters may help delay diabetes related retinal damage 7116 2Transporters may help delay diabetes related retinal damage 7116 3Nanotechnology and the media 3A The inside story 1364 1Nanotechnology and the media 3A The inside story 1364 2Promising Data ATIR Studies Presented by NIH Investigators 1980 1Promising Data ATIR Studies Presented by NIH Investigators 1980 2
(Date:11/22/2008)... Open enrollment is now happ...over expenses not covered by Medicare, and may als... consumers are now shopping online for instant quo...ort Collins, CO (PRWEB) November 21, 2008 -- MediG... for Medicare Supplement plans . Medicare Advant...
(Date:11/21/2008)...NGE COUNTY, Calif., Nov. 21 Album ...ting firm, launches a new program offering big bra...have taken the large, expensive ad agency process ...s with a very hands-on approach," says Matt Parker... 2002, combines experience and proven brand-buildi...
(Date:11/21/2008)...s, parents and schools need to work together to st...DAY, Nov. 21 (HealthDay News) -- Behavior that was...ized as bullying. , And as mounting research sh... victim, mental-health professionals, schools, par...ew ways to combat this threatening behavior. ,...
(Date:11/21/2008)... TALLAHASSEE, Fla. -- A Florida State University C...ang has discovered an important new layer of regul... to a greater understanding of the way cancer begi... sciences at the College of Medicine, said the fin... cancer and could lead to the design of new drugs ...
Breaking Medicine News(10 mins):Health News:MediGap Advisors Announces Open Enrollment for Medicare Supplement Plans 2Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3
...growth of colon polyps to half, it doubles the ris...by two significant studies published in the Aug. 3...e opinions of Bruce M. Psaty, M.D., Ph.D., and Joh...iversity of Washington were also published along w...
... only reverses the arterial dysfunction caused by ...ame arteries compared to before the meal, accordin...dings, reported in the European Journal of Applied...us on the effect food has on the body after the me...
...reas preoperative brain could effectively alter th...pear in the September issue of Radiology, states t...uage areas of the brain with functional magnetic r...e surgeons in pinpointing the brain tumors more ef...
...as challenged the view of The Sterling Council, of...alarm service, which the// Scottish public service...minced words that the ruling is a target at the we...ruly a mockery of the free care provided for the e...
Other Medicine News:Health News:Celebrex- pros and cons 2Health News:A Serving of Exercise After That Saturated Fat 2Health News:fMRI Prior to surgery Could Help In Outcome Of Tumor Surgery 2Health News:fMRI Prior to surgery Could Help In Outcome Of Tumor Surgery 3
Bandeau Bra
Bras and Breast Support
Compression Bra
Constructed from soft Shur-grip foam and velcro closure for easy application and - reapplication
Medicine Products: